Not registered yet? Please contact our project manager Sonja Leissner . This area is only for members of the research consortium.

News

23 June 2026

DECISION Video Series Complete: Research Explained Beyond the Scientific Community

We are delighted to announce the completion of the DECISION video series, a collection of short explainer videos translating key scientific findings from the project into accessible, engaging stories.

Across eight videos, DECISION researchers present important discoveries on topics ranging from immune dysfunction and epigenetic regulation to extracellular vesicles, single-cell analyses, and novel models for MASH-cirrhosis. Together, these videos offer insights into the mechanisms driving acute decompensation of cirrhosis and acute-on-chronic liver failure, while highlighting how DECISION research is contributing to improved prediction, monitoring, and treatment strategies.

Designed for clinicians, general practitioners, researchers, patients, and interested members of the public, the series aims to make complex science easier to understand without sacrificing scientific accuracy.

🎥 Watch the complete YouTube playlist.

A heartfelt thank you goes to all researchers who contributed their expertise, time, and enthusiasm to this initiative.

More news

News

02 June 2026

Single-Cell Analysis Reveals Early Immune Cell Energy Failure in Cirrhosis

Patients with cirrhosis can experience sudden clinical deterioration, progressing from acute decompensation to acute-on-chronic liver failure. However, the biological processes that precede this transition are not fully understood.

In this study from the DECISION project, we used single-cell technologies to investigate immune cell function at an unprecedented level of detail.

By analyzing thousands of individual immune cells from patients with advanced liver disease, we identified a consistent pattern: monocytes show a marked loss of energy production before organ failure develops. This dysfunction is linked to impaired mitochondrial activity, leaving the cells present but functionally compromised.

Importantly, this monocyte-specific energy failure was observed across large patient cohorts and was associated with infections, disease progression, and reduced survival.

These findings indicate that immune dysfunction in cirrhosis develops gradually at the level of cellular metabolism. Understanding how immune cells lose their energy may help explain why patients become vulnerable to complications and may inform future therapeutic strategies aimed at preserving immune function.

🎥 Watch the video!
📖 We’ll link the paper once it’s published.

More news

Events

1 June 2026

This was EASL2026!

What a stimulating event this was again! We're still full of new ideas and still ring with most of our discussions. EASL Congress 2026, held in Barcelona from 26 May to 30 May, just was a fabulous experience throughout. What was it like? Where did DECISION members present? What else was there to do? Welcome to 'This was EASL2026!'.

→ Click to open conference impressions
More events

Our Vision

DECISION strives to better understand the pathophysiology of decompensated cirrhosis leading to acute-on-chronic liver failure (ACLF) at the systems level by taking advantage of already existing large and clinically well characterized patient cohorts. The ultimate goal is to significantly reduce mortality through combinatorial therapies that are tailored to the specific needs of individual patients. Part of this endeavour is to develop a reliable prognostic test and a robust response test.

Learn more

Why it matters

In 2013, cirrhosis was responsible for 1.2 million deaths worldwide. While most cirrhosis patients initially do not show symptoms, acute decompensation of cirrhosis, defined as the body’s inability to cope with the progressing dysfunctionality of the liver, leads to drastic symptoms. Decompensation is characterized by the development of ascites, hepatic encephalopathy, jaundice, or gastrointestinal haemorrhage, and is often a turning point for cirrhosis.

Learn more